Finance

Lists
LINCOLN:NSE
Lincoln Pharmaceuticals Ltd
₹580,00
-0,96%
(-5,65) 1D
1 Okt., 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for LINCOLN...
Open
₹584,00
High
₹585,65
Low
₹572,25
Mkt. cap
11,67 mjd
Avg. vol.
30,96 k
Volume
61,90 k
Dividend
0,31%
Quarterly dividend
₹0,45
Ex-dividend date
11 Sep. 2026
P/E ratio
12,04
52-wk high
₹770,00
52-wk low
₹440,00
EPS
₹48,16
Shares outstanding
20,00 m
No. of employees
1 k
Open
₹584,00
High
₹585,65
Low
₹572,25
Mkt. cap
11,67 mjd
Avg. vol.
30,96 k
Volume
61,90 k
Dividend
0,31%
Quarterly dividend
₹0,45
Ex-dividend date
11 Sep. 2026
P/E ratio
12,04
52-wk high
₹770,00
52-wk low
₹440,00
EPS
₹48,16
Shares outstanding
20,00 m
No. of employees
1 k
News stories
From web sources and news partners
Profile
Lincoln Pharmaceuticals Limited is an Indian multinational pharmaceutical company headquartered in Ahmedabad, Gujarat, India. The company is engaged in the manufacturing, marketing and distribution of pharmaceutical products. Lincoln Pharmaceuticals is listed on National Stock Exchange of India and Bombay Stock Exchange. Wikipedia
About Lincoln Pharmaceuticals Ltd
CEO-
Employees1,35 k
Founded1979
Headquarters-
SectorPharmaceutical industry
Websitelincolnpharma.com
Last report
13 Aug. 2026
Fiscal period
Q1 2027
EPS / Est. (INR)
- / -
Revenue / Est. (INR)
1,77 mjd / -
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
1,63 mjd
1,66 mjd
1,87 mjd
1,77 mjd
Cost of goods sold
767,46 m
759,60 m
967,33 m
851,43 m
Cost of revenue
767,46 m
759,60 m
967,33 m
851,43 m
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
303,56 m
306,18 m
389,12 m
333,10 m
Operating expense
648,09 m
704,87 m
684,68 m
685,91 m
Total operating expenses
1,42 mjd
1,46 mjd
1,65 mjd
1,54 mjd
Operating income
218,09 m
198,75 m
220,76 m
235,48 m
Other non operating income
72,32 m
151,46 m
-379,32 m
242,65 m
EBT including unusual items
288,11 m
347,22 m
167,03 m
475,54 m
EBT excluding unusual items
288,11 m
347,22 m
146,26 m
475,54 m
Income tax expense
88,27 m
61,22 m
50,68 m
113,19 m
Effective tax rate
30,64%
17,63%
30,34%
23,80%
Other operating expenses
308,34 m
361,49 m
258,73 m
313,96 m
Net income
199,84 m
286,00 m
116,35 m
362,34 m
Net profit margin
12,23%
17,20%
6,21%
20,44%
Earnings per share
-
-
-
-
Interest and investment income
-
-
82,21 m
-
Interest expense
-2,31 m
-2,98 m
-
-2,59 m
Net interest expenses
-2,31 m
-2,98 m
82,21 m
-2,59 m
Depreciation and amortization charges
36,19 m
37,21 m
36,83 m
38,84 m
EBITDA
253,58 m
230,69 m
256,62 m
271,73 m
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme